• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    GeoVax Labs, Inc. - Common Stock (NQ:GOVX)

    1.170 -0.080 (-6.40%)
    Streaming Delayed Price Updated: 11:24 AM EDT, Jul 7, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 176,676
    Open 1.220
    Bid (Size) 1.170 (2,200)
    Ask (Size) 1.180 (600)
    Prev. Close 1.250
    Today's Range 1.170 - 1.230
    52wk Range 0.9631 - 23.10
    Shares Outstanding 2,172,309
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    GeoVax Highlights Continued U.S. Government Investment in Orthopox Preparedness as Strategic Validation of Long-Term Vaccine Readiness
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Economy
    GeoVax Highlights Continued U.S. Government Investment in Orthopox Preparedness as Strategic Validation of Long-Term Vaccine Readiness
    Recent Federal Procurement Reinforces the Importance of Sustained Investment in Domestic Vaccine Manufacturing and Diversified Medical Countermeasures 
    Via TheNewswire.com
    Topics Economy

    Performance

    YTD
    -77.4%
    -77.4%
    1 Month
    -12.7%
    -12.7%
    3 Month
    -6.4%
    -6.4%
    6 Month
    -75.4%
    -75.4%
    1 Year
    -90.7%
    -90.7%

    More News

    Read More
    News headline image
    GeoVax Highlights Strategic Implications of Recent Gedeptin(R) Findings for Checkpoint-Resistant Cancers
    Via NewMediaWire
    GeoVax Highlights Strategic Implications of Recent Gedeptin(R) Findings for Checkpoint-Resistant Cancers
    Via TheNewswire.com
    News headline image
    GeoVax Highlights Peer-Reviewed Research Supporting Gedeptin(R) Potential to Enhance Cancer Immunotherapy Responses
    Via NewMediaWire
    GeoVax Highlights Peer-Reviewed Research Supporting Gedeptin(R) Potential to Enhance Cancer Immunotherapy Responses
    Via TheNewswire.com
    News headline image
    GeoVax CEO Highlights Renewed Strategic Interest in Vaccine Platforms and Infectious Disease Innovation
    Via NewMediaWire
    GeoVax CEO Highlights Renewed Strategic Interest in Vaccine Platforms and Infectious Disease Innovation
    Via TheNewswire.com
    News headline image
    GeoVax CEO Welcomes FIFA World Cup 2026 While Addressing Biothreat Readiness
    Via NewMediaWire
    GeoVax CEO Welcomes FIFA World Cup 2026 While Addressing Biothreat Readiness
    Via TheNewswire.com
    News headline image
    Is Co-Diagnostics National Security’s Next Diagnostic Pick? ↗
    Via MarketBeat
    Keep an eye on the top gainers and losers in Wednesday's session. ↗
    Via Chartmill
    Let's uncover which stocks are experiencing notable gaps during today's session. ↗
    Via Chartmill
    News headline image
    Registration Now Open for Tribe Public CEO Presentation and Q&A Webinar Event
    Via TheNewswire.com
    News headline image
    Registration Now Open for Tribe Public CEO Presentation and Q&A Webinar Event
    Via NewMediaWire
    News headline image
    Stocks to Watch: NDRA, SBFM, GOVX, HIVE, ANY Trading Actively NOW!
    Via AB Newswire
    Topics Artificial Intelligence
    News headline image
    ENDRA Life Sciences (NASDAQ: NDRA) Beats Q1 Expectations, TAEUS® Liver Imaging Advances and Strategic Review Acceleration Fuels Investor Awareness
    Via AB Newswire
    News headline image
    GeoVax Accelerates Focus on GEO-MVA Commercialization and Advancement of Oncology Program Gedeptin(R)
    Via NewMediaWire
    GeoVax Accelerates Focus on GEO-MVA Commercialization and Advancement of Oncology Program Gedeptin(R)
    Via TheNewswire.com
    Which stocks are experiencing notable movement on Friday? ↗
    Via Chartmill
    Keep an eye on the top gainers and losers in Friday's session. ↗
    Via Chartmill
    Friday's session: gap up and gap down stocks ↗
    Via Chartmill
    Discover the top movers in Friday's pre-market session. ↗
    Via Chartmill
    The trading volume of these stocks is deviating from the norm in today's session. ↗
    Via Chartmill
    News headline image
    GeoVax Comments on Escalating Bundibugyo Ebola Outbreak and Growing Need for Flexible Biodefense Vaccine Platforms
    Via NewMediaWire

    Frequently Asked Questions

    Is GeoVax Labs, Inc. - Common Stock publicly traded?
    Yes, GeoVax Labs, Inc. - Common Stock is publicly traded.
    What exchange does GeoVax Labs, Inc. - Common Stock trade on?
    GeoVax Labs, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for GeoVax Labs, Inc. - Common Stock?
    The ticker symbol for GeoVax Labs, Inc. - Common Stock is GOVX on the Nasdaq Stock Market
    What is the current price of GeoVax Labs, Inc. - Common Stock?
    The current price of GeoVax Labs, Inc. - Common Stock is 1.170
    When was GeoVax Labs, Inc. - Common Stock last traded?
    The last trade of GeoVax Labs, Inc. - Common Stock was at 07/07/26 11:24 AM ET
    What is the market capitalization of GeoVax Labs, Inc. - Common Stock?
    The market capitalization of GeoVax Labs, Inc. - Common Stock is 2.54M
    How many shares of GeoVax Labs, Inc. - Common Stock are outstanding?
    GeoVax Labs, Inc. - Common Stock has 3M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.